Key facts
- XII Medical’s last known valuation is $117.0M.
- It has raised $82.6M across 3 recorded rounds; the latest was Early Stage VC ($22.5M) in Aug 2024.
- Notable investors include JobsOhio Ventures, Omega Funds, CincyTech, Ohio Department of Development, Ajax Health — 10 tracked in total.
- XII Medical has filed 3 Form Ds with the SEC since 2022, most recently Aug 2024 ($22.5M sold to 11 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for XII Medical
Funding rounds
3 roundsAbout XII Medical
Developer of an implantable neurostimulation device designed to alleviate sleep apnea. The company develops a minimally invasive outpatient technology that does not allow the muscles in the throat to temporarily relax, and avoids blockage of the airway during sleep, enabling patients to proactively increase oropharyngeal airflow.
- Sector
- Healthcare
- HQ
- Union City, CA, United States
- Founded
- 2017
- Employees
- 36
- Website
- xiimedical.com/
- Ownership
- Privately Held (backing)
XII Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in XII Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on XII Medical in its N-PORT filings yet. We sweep new filings monthly.